# Mycobacterium tuberculosis Complicating an Elective Right Total Knee Arthroplasty

**Authors:** Edward Eusanio, Brian Shaw, Mario Madruga, Melinda Madden, Steve Carlan

PMC · DOI: 10.7759/cureus.101774 · Cureus · 2026-01-18

## TL;DR

A rare case of tuberculosis infecting a prosthetic knee joint in a patient with no prior TB history is reported, highlighting the challenges in diagnosis and treatment.

## Contribution

This case emphasizes the importance of considering TB in culture-negative joint infections, especially when standard treatments fail.

## Key findings

- TB prosthetic joint infection was diagnosed using next-generation sequencing after routine cultures failed.
- The patient initially responded to standard TB therapy but later developed drug-resistant TB and multiorgan failure.
- The case underscores the need for high suspicion of TB in atypical joint infections.

## Abstract

Mycobacterium tuberculosis primarily causes pulmonary disease but can involve extrapulmonary sites, including bones and joints. Tuberculosis (TB) prosthetic joint infections (TB-PJIs) are rare, often diagnosed late due to low suspicion, indolent progression, and frequent culture negativity.

A 73-year-old man from Guyana underwent elective right total knee arthroplasty for osteoarthritis. Postoperatively, he developed a prosthetic joint infection without an identifiable pathogen by routine cultures. Advanced testing detected Mycobacterium tuberculosis complex via next-generation 16S rRNA gene sequencing. The patient initially improved with RIPE (rifampin, isoniazid, pyrazinamide, and ethambutol) therapy but subsequently developed disseminated disease, raising concern for suspected drug-resistant TB. His hospital course was further complicated by bladder rupture and multiorgan failure, leading to death.

TB-PJIs may present without pulmonary symptoms or prior TB history and should be suspected in culture-negative joint infections, particularly when conventional therapy fails. Treatment may be further complicated by suspected multidrug resistance, as illustrated in this case.

## Linked entities

- **Chemicals:** rifampin (PubChem CID 135398735), isoniazid (PubChem CID 3767), pyrazinamide (PubChem CID 1046), ethambutol (PubChem CID 14052)
- **Diseases:** tuberculosis (MONDO:0018076), osteoporosis (MONDO:0005298), multiorgan failure (MONDO:0043726)
- **Species:** Mycobacterium tuberculosis (taxon 1773)

## Full-text entities

- **Diseases:** seroma (MESH:D049291), hematoma (MESH:D006406), abscess (MESH:D000038), inflammation (MESH:D007249), MDR-TB (MESH:D018088), gout (MESH:D006073), pain (MESH:D010146), hematuria (MESH:D006417), weakness (MESH:D018908), lung infiltrates (MESH:D008171), bladder rupture (MESH:D012421), PJI (MESH:C537702), multiorgan failure (MESH:D051437), swelling (MESH:D004487), asthma (MESH:D001249), meningitis (MESH:D008580), emphysema (MESH:D004646), blood loss (MESH:D016063), immune reconstitution inflammatory syndrome (MESH:D054019), interstitial opacities (MESH:D003318), respiratory failure (MESH:D012131), knee pain (MESH:D046788), fever (MESH:D005334), bladder injury (MESH:D001745), myelodysplastic syndrome (MESH:D009190), Osteoarticular TB (MESH:D014394), hypotension (MESH:D007022), Spinal lesions (MESH:D013122), tuberculoma (MESH:D014375), osteoarthritis (MESH:D010003), arthritis (MESH:D001168), encephalopathy (MESH:D001927), hypertension (MESH:D006973), death (MESH:D003643), thrombocytopenia (MESH:D013921), joint effusion (MESH:D000080324), Prosthetic joint infections (MESH:D007239), leukocytosis (MESH:D007964), lymphangitis (MESH:D008205), toxicities (MESH:D064420), Pott's disease (MESH:D014399), type 2 diabetes mellitus (MESH:D003924), TB (MESH:D014376), erythema (MESH:D004890), MRI abnormalities (MESH:C564543), infectious (MESH:D003141)
- **Chemicals:** isoniazid (MESH:D007538), pyrazinamide (MESH:D011718), clindamycin (MESH:D002981), levofloxacin (MESH:D064704), cefepime (MESH:D000077723), polyethylene (MESH:D020959), AFB (-), ethambutol (MESH:D004977), Linezolid (MESH:D000069349), rifampin (MESH:D012293), steroids (MESH:D013256), daptomycin (MESH:D017576), glucose (MESH:D005947)
- **Species:** Mycobacterium tuberculosis complex (species group) [taxon 77643], Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Mycobacterium tuberculosis (species) [taxon 1773], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12911139/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12911139/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12911139/full.md

---
Source: https://tomesphere.com/paper/PMC12911139